Finance

Beta
Lists
301080:SHE
Acrobiosystems Co Ltd
CNÂ¥36.47
-4.28%
(-1.63) 1D
Jun 8, 3:04:37 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301080...
Open
CNÂ¥37.12
High
CNÂ¥38.09
Low
CNÂ¥35.87
Mkt. cap
6.37B
Avg. vol.
3.12M
Volume
2.76M
Dividend
1.65%
Quarterly dividend
CNÂ¥0.15
Ex-dividend date
Jun 11, 2026
P/E ratio
35.60
52-wk high
CNÂ¥71.49
52-wk low
CNÂ¥35.87
EPS
CNÂ¥1.02
Shares outstanding
167.18M
No. of employees
926
Open
CNÂ¥37.12
High
CNÂ¥38.09
Low
CNÂ¥35.87
Mkt. cap
6.37B
Avg. vol.
3.12M
Volume
2.76M
Dividend
1.65%
Quarterly dividend
CNÂ¥0.15
Ex-dividend date
Jun 11, 2026
P/E ratio
35.60
52-wk high
CNÂ¥71.49
52-wk low
CNÂ¥35.87
EPS
CNÂ¥1.02
Shares outstanding
167.18M
No. of employees
926
News stories
From sources across the web
About Acrobiosystems Co Ltd
CEO-
Employees926
FoundedJul 22, 2010
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
200.87M
225.62M
225.13M
235.59M
Cost of goods sold
42.72M
-6.98M
84.82M
22.73M
Cost of revenue
42.72M
-6.98M
84.82M
22.73M
Research and development expenses
47.89M
45.38M
46.84M
45.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
92.41M
92.67M
122.40M
102.50M
Operating expense
140.57M
137.54M
177.04M
152.44M
Total operating expenses
183.29M
130.56M
261.86M
175.17M
Operating income
17.59M
95.06M
-36.73M
60.41M
Other non operating income
1.80M
-2.28M
-1.65M
-3.88M
EBT including unusual items
46.02M
48.82M
31.12M
49.35M
EBT excluding unusual items
37.56M
103.08M
-34.31M
65.37M
Income tax expense
2.95M
536.14K
-2.06M
3.09M
Effective tax rate
6.41%
1.10%
-6.60%
6.26%
Other operating expenses
24.07K
-2.59M
8.93M
4.00M
Net income
43.23M
48.62M
33.14M
46.26M
Net profit margin
21.52%
21.55%
14.72%
19.63%
Earnings per share
-
-
-
-
Interest and investment income
15.13M
14.98M
13.95M
9.26M
Interest expense
-1.62M
-
-
-419.40K
Net interest expenses
13.51M
14.98M
13.95M
8.84M
Depreciation and amortization charges
-
-
-
-
EBITDA
27.92M
102.26M
-25.71M
71.42M
Gain or loss from assets sale
-
-
-67.00K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more